New italian registry aims to unlock secrets of rare brain disease

NCT ID NCT06844877

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is building a registry of 50 people with NCL, a rare and severe brain disorder. Researchers will collect detailed clinical data, biomarkers, and patient-reported outcomes over time. The goal is to better understand the disease's natural history and develop tools that can be used in future treatment trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this registry could provide the detailed data needed to design better clinical trials for NCL treatments.

What could go wrong

This is an observational registry, not a treatment trial. It will not directly improve symptoms or slow the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEURONAL CEROID LIPOFUSCINOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neuronal ceroid lipofuscinosis Neuronal Ceroid-Lipofuscinoses

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • IRCCS Fondazione Stella Maris

    RECRUITING

    Pisa, 56128, Italy

    Contact Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••